Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Carcinoma of Unknown Primary
			Colorectal Cancer
2		Additional conditions recognized in this trial
			Carcinoma
			Colorectal Neoplasms
			Neoplasms, Unknown Primary
3		More general conditions related to this trial
			Colonic Diseases
			Digestive System Diseases
			Digestive System Neoplasms
			Gastrointestinal Diseases
			Gastrointestinal Neoplasms
			Intestinal Diseases
			Intestinal Neoplasms
			Neoplasm Metastasis
			Neoplasms
			Neoplasms by Histologic Type
			Neoplasms by Site
			Neoplasms, Glandular and Epithelial
			Neoplastic Processes
			Pathologic Processes
			Rectal Diseases
4		Interventions listed in this trial
			fluorouracil
			irinotecan hydrochloride
			leucovorin calcium
			conventional surgery
			radiation therapy
5		Additional drug interventions recognized in this trial
			Camptothecin
			Irinotecan
			Leucovorin
6		More general drug interventions related to this trial
			Antimetabolites
			Antimetabolites, Antineoplastic
			Antineoplastic Agents
			Antineoplastic Agents, Phytogenic
			Enzyme Inhibitors
			Growth Substances
			Immunologic Factors
			Immunosuppressive Agents
			Micronutrients
			Molecular Mechanisms of Pharmacological Action
			Pharmacologic Actions
			Physiological Effects of Drugs
			Therapeutic Uses
			Vitamin B Complex
			Vitamins
7		Sponsors listed in this trial
			St. Jude Children's Research Hospital
			National Cancer Institute (NCI)